ArticleBMJ (Clinical research ed.)2018

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.

Devin Abrahami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.